Pathfinder Cell Therapy, Inc. Share Price Other OTC
Equities
PFND
US70319A1060
Biotechnology & Medical Research
Sales 2013 | 0.05 4.5 | Sales 2014 | - | Capitalization | 534K 44.48M |
---|---|---|---|---|---|
Net income 2013 | -1M -83.34M | Net income 2014 | -1M -83.34M | EV / Sales 2013 | 24,60,23,185 x |
Net Debt 2013 | 3.94M 329M | Net Debt 2014 | 4.96M 413M | EV / Sales 2014 | - |
P/E ratio 2013 |
-5.48
x | P/E ratio 2014 |
-0.38
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 02/11/02 |
John Benson
DFI | Director of Finance/CFO | 62 | 02/11/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 02/11/02 |
John Benson
DFI | Director of Finance/CFO | 62 | 02/11/02 |
1st Jan change | Capi. | |
---|---|---|
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.22% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |